Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Down 14% from All-Time Highs, is This Dividend King a Buy on the Dip?

With a strong product portfolio, this growth and income stock is an excellent long-term investment.

ABBV : 155.34 (-1.10%)
$SPX : 5,306.04 (+0.02%)
Abbvie Stock: Is Wall Street Bullish or Bearish?

Although Abbvie stock has been lagging behind the broader market over the past year, Wall Street analysts are still moderately bullish about its outlook.

ABBV : 155.34 (-1.10%)
$SPX : 5,306.04 (+0.02%)
PPH : 88.88 (-1.10%)
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead

AbbVie's returns haven't been great this year, but investors shouldn't overlook this promising growth stock.

NVDA : 1,139.01 (+6.98%)
ABBV : 155.34 (-1.10%)
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

These dividend stocks are ideal for investors seeking long-term passive income.

ABBV : 155.34 (-1.10%)
LOW : 215.37 (+0.07%)
PSA : 270.49 (-0.70%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

ONCY : 1.1000 (+0.92%)
ONC.TO : 1.49 (-2.61%)
RENB : 1.4700 (+3.52%)
CYTO : 1.6100 (-9.55%)
PFE : 28.30 (-2.01%)
ABBV : 155.34 (-1.10%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

ONCY : 1.1000 (+0.92%)
ONC.TO : 1.49 (-2.61%)
RENB : 1.4700 (+3.52%)
CYTO : 1.6100 (-9.55%)
PFE : 28.30 (-2.01%)
ABBV : 155.34 (-1.10%)
A Must-Own Stock for Any Portfolio

This company offers growth, high yield, and dividend growth.

ABBV : 155.34 (-1.10%)
2 Billion More Reasons to Buy AbbVie Stock

This pharma giant just made a smart strategic acquisition.

ABBV : 155.34 (-1.10%)
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?

Revenue growth during what should be a disastrous patent cliff is encouraging.

CERE : 41.00 (-0.80%)
ABBV : 155.34 (-1.10%)
10 Stocks to Build a Dividend Portfolio With

All 10 of these stocks pay reliable and growing dividends.

GOOGL : 176.40 (+0.81%)
GOOG : 178.02 (+0.96%)
HD : 328.70 (+1.11%)
KO : 61.82 (-0.29%)
CAT : 346.47 (-0.70%)
CVX : 159.04 (+0.82%)
V : 270.98 (-1.28%)
NEE : 77.53 (+1.20%)
ABBV : 155.34 (-1.10%)
PLD : 105.00 (+0.24%)
MSFT : 430.32 (+0.04%)

Barchart Exclusives

Should Nvidia Consider Paying a Special Dividend in 2024 to Reward Shareholders?
Nvidia's dividend hasn't kept pace with its earnings growth, and after accounting for the steep rise in its share price, the company's dividend yield is a mere 0.038%. Should NVDA consider a special dividend in 2024 to reward shareholders? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar